#sputnik v russia vaccine

[klbmsw]

Are you sure he didn't fall out a window??

[ironymous]

Russians are also "dying suddenly" — Edward Slavsquat

“[T]he two technologies that underpin AstraZeneca’s vaccine and Sputnik V are very similar” — Gamaleya Center Director Alexander Gintsburg (source: Sputnik News)Since the start of the global genetic injection campaign in 2021, media reports detailing the “sudden deaths” of athletes have gradually become part of the new normal.It’s a worldwide phenomenon—and Russia is no exception,… Russians are…

[decentralvaccine]

Russian Vaccine Scientist Discovered Dead

A top Russian scientist who helped develop the country's Sputnik V COVID-19 vaccine was found dead in his apartment on Thursday, according to a Telegram post by the Investigative Committee of the Russian Federation.

The death of Andrey Botikov, who worked as a senior researcher at the Gamaleya National Research Center for Ecology and Mathematics, is being investigated as a murder, the statement said.

According to investigators, a 29-year-old man strangled the 47-year-old virologist with a belt during an argument and fled.

[candyswift-ny]

Two Faces of Adenovirus - A Time to Kill, A Time to Heal

Viruses are a kind of non-cellular organisms that are tiny to the nanometer level, with a simple structure that only has a protein shell and a long nucleic acid chain as genetic material. It cannot be independently metabolized but must be parasitic in living cells and multiply in a replication mode. It is weak but also strong, and human beings have to face the two-sided nature of a kind.

Adenovirus is such a virus that can infect human body. They are widespread in nature and can cause infections of the respiratory tract, eyes, gastrointestinal tract, and urinary system. They can cause regional transmission in highly confined, crowded and humid environments. But the advancement of science and technology helps us discover that this type of virus can also be used to fight tumors and even the novel coronavirus disease, COVID-19, that has recently raged around the world.

· Adenovirus Infection Can Be Dangerous

Adenovirus infection will cause many uncomfortable symptoms, including symptoms of upper respiratory tract infection (fever, sore throat, nasal congestion and other common cold symptoms), conjunctivitis (such as pharyngeal conjunctivitis, conjunctivitis, epidemic keratoconjunctivitis), gastrointestinal infection (diarrhea, more common in children under 5 years old), urinary tract infections, hemorrhagic cystitis, etc.

Adenovirus infection is a contagious disease and should be actively prevented. Adenovirus transmission mainly includes contact transmissions of respiratory droplets, pollutants and excrement, and eye secretions.

· Adenovirus Help Fight Tumors

Oncolytic viruses are currently an important method in the field of tumor immunotherapy. At present, Adenoviruses are the most used type in clinical trials. Oncolytic adenovirus is a genetically engineered adenovirus that can selectively replicate and express in tumor cells, thereby lysing tumor cells.

In 1996, since the world's first oncolytic adenovirus ONXY-015 was launched in clinical research, it has been widely used in scientific research, involving a variety of solid tumors. Oncolytic adenovirus combined with radiotherapy, chemotherapy, and targeted drug therapy are also proved to be more effective treatment options. Further clinical research will continue to explore the potential of oncolytic virus combined with other therapies.

· Adenovirus Vaccine for SARS-CoV-2

Adenovirus-vectored COVID-19 vaccines are one of the hot topics in global news. Johnson & Johnson’s JNJ-78436735, CanSino Biologics’ Convidicea (AD5-nCoV) and Russia’s Sputnik V, AZD1222 are all examples of this type. So what kind of vaccine is it? How does it work?

Like all vaccines, this method is designed to trick our body into getting infected. These homemade spike proteins will train our bodies to detect and terminate any actual SARS-CoV-2 infection before the virus causes severe damage. The adenovirus vector COVID-19 vaccine constructs the gene of S protein of SARS-CoV-2 into the adenovirus genome, and the shell is still the normal shell protein of the adenovirus. Therefore, when adenovirus infects host cells, the genes encoding the SARS-CoV-2 S protein are released to the host cell, and S protein is synthesized in the cytoplasm, which stimulates a series of immune responses.

The advantage of an adenovirus-based vaccine is that it can induce humoral and cellular immunity at the same time. Humoral immunity produces antibodies that bind to viruses, preventing viruses from entering human cells, that’s to say, viruses are recognized, swallowed, and degraded by macrophages outside the cells. For viruses that have been lucky enough to enter cells, they can be recognized by cellular immune mechanisms and cytokine secreted by killer T cells to lyse the infected cells.

[marketnewupdate]

Sputnik V Director Found Strangled in Moscow Office

The scientific community was left reeling this week after Alexander Ginzburg, the director of the Gamaleya Institute in Moscow, was found strangled in his office on Monday. Ginzburg was the driving force behind Russia’s Sputnik V COVID-19 vaccine, which has been approved for use in over 70 countries.

Authorities are investigating the death, which many believe may have been a targeted attack. The loss of Ginzburg is a significant blow to Russia’s efforts to combat the COVID-19 pandemic, as the Sputnik V vaccine has been a key component of the country’s vaccination drive.

The incident has also raised concerns about the safety of scientists and researchers involved in developing COVID-19 vaccines. Many have faced threats and intimidation from anti-vaccine activists and conspiracy theorists, underscoring the importance of protecting the independence and integrity of scientific research.

Ginzburg’s contributions to the fight against COVID-19 will not be forgotten. His tragic death serves as a stark reminder of the risks and challenges faced by those working on the frontlines of scientific research. The scientific community and the world at large are mourning the loss of a brilliant mind and a pioneering scientist.

Source: https://www.marketupdates.info/2023/03/04/director-of-gamaleya-institute-behind-sputnik-v-covid-vaccine-found-strangled-in-his-office/

[parolim-prlm]

Top scientist behind Russia's Sputnik V Covid vaccine strangled to death with a belt

MOSCOW: Andrey Botikov, one of the scientists who helped to create the Russian Covid-19 vaccine Sputnik V, was strangled to death with a belt at his apartment here and police have arrested a suspect in connection with the murder, according to a Russian media report on Saturday.Botikov, 47, who worked as a senior researcher at the Gamaleya National Research Center for Ecology and Mathematics, was…

[filmishine]

Top Scientist Behind Russia's Covid Vaccine "Strangled": Report

According to investigators, a 29-year-old young man strangled Botikov. Moscow: Andrey Botikov, one of the scientists who helped to create the Russian COVID-19 vaccine Sputnik V, was strangled with a belt at his apartment here and police have arrested a suspect in connection with the murder, according to a Russian media report on Saturday. Botikov, 47, who worked as a senior researcher at the…

[sudeepkedar]

Europe Clinical Trials Market To Hit USD 13.8 Bn By 2027

Europe Clinical Trials Market To Hit USD 13.8 Bn By 2027. Owing to the emergency authorization of several COVID-19 products, Europe clinical trials market trends are registering a steady advancement. Until now, only seven COVID-19 vaccines have been authorized by the World Health Organization (WHO). With more candidates in the pipeline, there will be significant addition to the list of approved products by Sinovac, AstraZeneca, Pfizer / BioNTech, Sinopharm, Moderna, Bharat Biotech, and Johnson & Johnson.

The changing approval process for clinical trials for COVID-19 vaccines across the Netherlands, Spain, Germany, Denmark, and Belgium is transforming the industry forecast. With the EU’s introduction of a new clinical trials regulation that is expected to be in effect by January 2022, the region will see more stringent standards, at the same time becoming a hub for clinical research investments.

Get sample copy of this research report @    

https://www.graphicalresearch.com/request/2003/sample

In a social media interaction in November 2021, WHO chief scientist Dr. Soumya Swaminathan revealed that over 129 potential COVID-19 vaccines have reached clinical trials, while additional 194 are expected to progress at a robust pace over the next few months. Due to the upcoming variety of COVID-19 products, Europe clinical trials industry trends are clearly making a headway.

In France, individuals aged over 65 years will need to produce proof of having received a booster shot for visiting restaurants, attending cultural events, and traveling on intercity trains. As per the British government’s November 2021 records, over 100,00 NHS workers in the U.K. remain unvaccinated. Due to the unique responsibilities carried by health workers, a new rule mandating the vaccination of this staff will prove to be a major driver of the industry.

U.K. clinical trials market share represented nearly 13.5% of the total revenue in 2020. The country is offering a third booster to prevent further risk from the virus. Early phase clinical trials, i.e., phase I and II, are likely to gain momentum over the next five years in the U.K.

The oncology segment is anticipated to grow at over 5.9% CAGR between 2021 and 2027 in Europe clinical trials industry, driven by the spiraling cancer rate among Europeans. The high prevalence of prostate cancer, breast cancer, colorectal cancer, and lung cancer has called for a need for accelerated research in advanced therapeutics.

Request for customization @ https://www.graphicalresearch.com/request/2003/customize-this-report

While Europe is representative of nearly 10% of the global population, the regional cancer cases account for a massive 22% on a global scale, with almost 20% of annual cancer deaths. Owing to the rising burden of cancer in the region, numerous applications for clinical trials for cancer are being approved.

The following noteworthy developments across Russia clinical trials industry are paving the way for a stable growth:

·       In October 2021, Russian researchers announced that they will test Sputnik V’s two 0.5 ml doses of nasal spray in a mid-phase study. The enrollment target of the trial is set to 500 volunteers, with deadline being December 2023.

·       In the same month, BeiGene and Nanolek announced the first regulatory approval from Russian Ministry of Health for BRUKINSA, a treatment for patients suffering from mantle cell lymphoma (MCL)

·       One of the largest Russian biotech companies, BIOCAD, is simultaneously carrying out clinical trials in the EU, Russia, and China for its lung cancer candidate.

About Graphical Research:

Graphical Research is a business research firm that provides industry insights, market forecast and strategic inputs through granular research reports and advisory services. We publish targeted research reports with an aim to address varied customer needs, from market penetration and entry strategies to portfolio management and strategic outlook. We understand that business requirements are unique: our syndicate reports are designed to ensure relevance for industry participants across the value chain. We also provide custom reports that are tailored to the exact needs of the customer, with dedicated analyst support across the purchase lifecycle.

 Contact US:

Parikhit B. Corporate sales, Graphical Research Email: sales@graphicalresearh.com Web: https://www.graphicalresearch.com/

[digimakacademy]

Sputnik V वैक्सीन 92% असरदार, वैज्ञानिक अगली पीढ़ियों को सुनाएंगे सफलता की कहानी: रूस रूस की Sputnik V वैक्सीन लोगों को कोविड-19 से बचाने के लिए 92% असरदार है। वैक्सीन के अंतरिम ट्रायल नतीजों के आधार पर सोवरेन वेल्थ फंड ने यह दावा बुधवार को किया है। गौरतलब है कि वैक्सीन की रेस में रूस पश्चिमी देशों से आगे निकलने की कोशिश में है और अगस्त में ही उसने अपनी Sputnik V वैक्सीन को रजिस्टर करा लिया था। वहीं, पश्चिम का रूस के प्रयासों पर सवाल उठाना जारी है। …

[scishow]

On August 11th, Russia announced that they’ve approved the world’s first vaccine against COVID-19, but if and how it works is still unclear. So, what DO we know about Sputnik V?

[ironymous]

Putin, Sputnik V & mass vaccination

What role did Russia’s president play in Sputnik V’s development & deployment? Edward Slavsquat Aug 12, 2022 Putin & COVID: Part I This is Part I of an ongoing series, “Putin & COVID.” Read Part II here. What role has Putin played in Russia’s response to COVID? Is he waging a silent war to root out the clot-shot fanatics and Virus nannies in his country? Or has he enabled and supported…

[theradical-outlook]

Peruvian President reports of agreement on domestic production of Sputnik V

Peruvian President reports of agreement on domestic production of Sputnik V

According to the Pedro Castillo, Peru’s health minister will soon “submit the details with regards to this work ST PETERSBURG, RUSSIA – JULY 27, 2021: A nurse holds a package of the first component of the Gam-COVID-Vac (Sputnik V) COVID-19 vaccine at a tent in Park of the 300th Anniversary of St Petersburg. Alexander Demianchuk/TASS BUENOS AIRES, September 7. /TASS/. The Peruvian government has…

[altervera]

I've got vaccinated but it's Sputnik V so...

[everythingshouldbereality]

First consignment of Sputnik V vaccines from Russia arrive in Hyderabad

First consignment of Sputnik V vaccines from Russia arrive in Hyderabad

Image Source : ANI “First batch of SputnikV vaccine arrives in Hyderabad, India. As India battles the second wave of coronavirus, the first consignment of Russia’s Sputnik V vaccines arrived in Hyderabad. India is currently using two vaccines including Covishield and Covaxin. Russia’s Sputnik V is going to be the third Covid vaccine which will be administered to the people. “As Russia and India…